Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes.
about
Pharmacokinetic Model of the Transport of Fast-Acting Insulin From the Subcutaneous and Intradermal Spaces to Blood[Fast-acting insulin - new developments towards more flexibility for the patient].Reduction of postprandial glycemic excursions in patients with type 1 diabetes: a novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin.Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wearImproving patient acceptance of insulin therapy by improving needle designMicroneedles for drug and vaccine deliveryPharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion.Evaluation of Intradermal and Subcutaneous Infusion Set Performance Under 24-Hour Basal and Bolus Conditions.Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming.Insulin administration: selecting the appropriate needle and individualizing the injection technique.Ultrafast-acting insulins: state of the artEmerging micro- and nanotechnology based synthetic approaches for insulin delivery.Biomedical applications of microneedles in therapeutics: recent advancements and implications in drug delivery.Moving toward the ideal insulin for insulin pumps.Demonstration of ATP-dependent, transcellular transport of lipid across the lymphatic endothelium using an in vitro model of the lacteal.Improved Insulin Pharmacokinetics Using a Novel Microneedle Device for Intradermal Delivery in Patients with Type 2 Diabetes.Subcutaneous injection versus subcutaneous infusion of insulin: are the rates of absorption truly the same?Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes.
P2860
Q30300391-060DBDDD-0038-40EB-A433-B448D012BE91Q30313628-9FDE3B51-FC2E-4BEE-9519-302A6DDFD263Q35337607-D7CCD398-A865-43C8-AE1E-34D7B9319E1BQ35929406-440F937A-E53B-4083-8843-1FF5E8DFE3DDQ36051255-68A1F807-FD23-4E9A-A7E1-5FB026DB0601Q36164749-892291BD-3D42-4795-B698-3E05E718A9D5Q36229266-54980791-2CA2-4C92-8D4C-98400B059042Q36340397-46D677CB-2D5A-4048-891B-84E0A1125788Q37460129-1D8BF259-E7DE-4BAA-91B7-569765345FE8Q37921796-8BA0C49D-088B-4441-8F3A-491FDBF0D77BQ38037727-E33557E7-3602-47FE-9ED1-DED53867ACF7Q38195730-6853D4FC-56B7-453D-A2A0-2E40D67048CEQ38630763-1D6FC5AB-F9B8-4B69-A8ED-46107A8E20E4Q38631154-02A7BF50-C9F1-4E95-8B8A-F0F585283CC9Q39311671-08AB83C5-D108-4E81-9521-F83E19AB8077Q41172888-C3CC4362-503A-4D64-9ED1-DFA2B6F4D45AQ42959127-6EF01CF0-5DD5-4516-ACE5-DC66B9E89AA8Q46268392-01B3DC66-129B-4917-9B21-F78FC0416292
P2860
Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Microneedle-based intradermal ...... patients with type 1 diabetes.
@en
Microneedle-based intradermal ...... patients with type 1 diabetes.
@nl
type
label
Microneedle-based intradermal ...... patients with type 1 diabetes.
@en
Microneedle-based intradermal ...... patients with type 1 diabetes.
@nl
prefLabel
Microneedle-based intradermal ...... patients with type 1 diabetes.
@en
Microneedle-based intradermal ...... patients with type 1 diabetes.
@nl
P2093
P356
P1476
Microneedle-based intradermal ...... patients with type 1 diabetes.
@en
P2093
Christoph Kapitza
Diane E Sutter
Heinz-Joerg Kurth
Laurence Hirsch
Leszek Nosek
Noel G Harvey
Ronald J Pettis
Ulrike Hövelmann
P304
P356
10.1089/DIA.2010.0183
P577
2011-02-28T00:00:00Z